Literature DB >> 11083311

Hospitalization in the Program of All-Inclusive Care for the Elderly (PACE): rates, concomitants, and predictors.

D Wieland1, V L Lamb, S R Sutton, R Boland, M Clark, S Friedman, K Brummel-Smith, G P Eleazer.   

Abstract

BACKGROUND: The Program of All-Inclusive Care for the Elderly (PACE) replicates the model of comprehensive, community-based geriatric care pioneered by On Lok, that enrolls frail older adults who meet states' criteria for nursing home care, and that uses interdisciplinary teams to assess the participants and to deliver care in appropriate settings. As managed care, PACE receives capitated payment from Medicare and Medicaid. Thus, PACE's fiscal incentives are thought to be aligned with the goals of optimizing health, function, and quality of life through the delivery of effective primary, preventive, restorative, supportive, and palliative care and through the avoidance of inappropriate and expensive hospital and nursing home utilization.
OBJECTIVES: To describe short-term hospital utilization, hospital discharge diagnoses, time from enrollment to first hospitalization and its clinical predictors, and hospitalization in relation to mortality among PACE participants.
METHODS: Data on short-term hospitalization and participants were recovered from PACE's minimum data set. Bed use was evaluated in annual cross-sections of current participants. Primary hospital discharge diagnoses were available for discharges from September 1, 1993 through March 31, 1997. The time from enrollment to hospitalization was calculated for the participants (n = 5478) who were admitted between January 1, 1990 and March 31, 1997. The characteristics of this inception cohort were used to develop a Cox regression model of hospitalization. All PACE deaths were identified and the place of death was recovered, together with the medical records used in the hospital during PACE enrollment or 6 months before death.
RESULTS: Bed-days per 1,000 PACE participants per year were comparable with the general Medicare (fee-for-service) population, at 2,046 (in 1998) versus 2014 (in 1997) despite the greater morbidity and disability for PACE participants, as reflected in their enrollment characteristics and primary hospital discharge diagnoses. The time to hospitalization was 773 days (median); 95% confidence interval, 725, 814, and was predicted by disease, treatment, social and demographic factors. Whereas 8% of PACE deaths occurred in acute hospitals, less than one-third of the decedents spent any time in the hospital in the 6-month interval before death.
CONCLUSIONS: Overall, short-term hospital utilization among PACE participants is low in contrast with that for other older and disabled populations. Participant predictors of hospitalization in PACE are generally consistent with other studies in older clinical and community populations. Both utilization and risk vary considerably across PACE sites, independent of participant-level risk factors, hence suggesting that further investigation is required to study PACE's management of acute illness and hospitalization decisions. Critical to maintaining PACE's success is an understanding of the independent impact of the organization and the environment of health care on this management.

Entities:  

Mesh:

Year:  2000        PMID: 11083311     DOI: 10.1111/j.1532-5415.2000.tb02625.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  15 in total

1.  The growing pains of integrated health care for the elderly: lessons from the expansion of PACE.

Authors:  Diane L Gross; Helena Temkin-Greener; Stephen Kunitz; Dana B Mukamel
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

2.  A National Examination Of Long-Term Care Setting, Outcomes, And Disparities Among Elderly Dual Eligibles.

Authors:  Rebecca J Gorges; Prachi Sanghavi; R Tamara Konetzka
Journal:  Health Aff (Millwood)       Date:  2019-07       Impact factor: 6.301

3.  Geriatric palliative care in long-term care settings with a focus on nursing homes.

Authors:  Mary Ersek; Joan G Carpenter
Journal:  J Palliat Med       Date:  2013-08-28       Impact factor: 2.947

4.  Building care systems to improve access for high-risk and vulnerable veteran populations.

Authors:  Thomas P O'Toole; P A Pirraglia; D Dosa; C Bourgault; S Redihan; M B O'Toole; J Blumen
Journal:  J Gen Intern Med       Date:  2011-11       Impact factor: 5.128

5.  The hidden costs of rebalancing long-term care.

Authors:  R Tamara Konetzka
Journal:  Health Serv Res       Date:  2014-06       Impact factor: 3.402

6.  Diagnostic study, design and implementation of an integrated model of care in France: a bottom-up process with continuous leadership.

Authors:  Matthieu de Stampa; Isabelle Vedel; Claire Mauriat; Emmanuel Bagaragaza; Christelle Routelous; Howard Bergman; Liette Lapointe; Bernard Cassou; Joel Ankri; Jean-Claude Henrard
Journal:  Int J Integr Care       Date:  2010-02-18       Impact factor: 5.120

7.  Health insurance status and the care of nursing home residents with advanced dementia.

Authors:  Keith S Goldfeld; David C Grabowski; Daryl J Caudry; Susan L Mitchell
Journal:  JAMA Intern Med       Date:  2013 Dec 9-23       Impact factor: 21.873

8.  Outcomes of Medicaid home- and community-based long-term services relative to nursing home care among dual eligibles.

Authors:  R Tamara Konetzka; Daniel H Jung; Rebecca J Gorges; Prachi Sanghavi
Journal:  Health Serv Res       Date:  2020-12       Impact factor: 3.402

Review 9.  A systematic review of different models of home and community care services for older persons.

Authors:  Lee-Fay Low; Melvyn Yap; Henry Brodaty
Journal:  BMC Health Serv Res       Date:  2011-05-09       Impact factor: 2.655

10.  Healthcare professionals and managers' participation in developing an intervention: a pre-intervention study in the elderly care context.

Authors:  Isabelle Vedel; Matthieu De Stampa; Howard Bergman; Joel Ankri; Bernard Cassou; François Blanchard; Liette Lapointe
Journal:  Implement Sci       Date:  2009-04-21       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.